These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2187801)

  • 1. Effect of proteolytic activity on virulence of Candida albicans in burned mice.
    Neely AN; Holder IA
    Infect Immun; 1990 Jun; 58(6):1527-31. PubMed ID: 2187801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida albicans growth studies: a hypothesis for the pathogenesis of Candida infections in burns.
    Neely AN; Orloff MM; Holder IA
    J Burn Care Rehabil; 1992; 13(3):323-9. PubMed ID: 1377693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.
    Neely AN; Miller RG; Holder IA
    Infect Immun; 1994 Jun; 62(6):2158-64. PubMed ID: 8188336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of challenge with Candida albicans strains with different levels of virulence on plasma proteins in burned mice.
    Neely AN; Childress CM; Holder IA
    Infect Immun; 1991 Apr; 59(4):1576-8. PubMed ID: 2004833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical trauma, Candida infection, and serum proteolytic activity.
    Miller RG; Neely AN
    J Surg Res; 1992 Sep; 53(3):263-7. PubMed ID: 1528052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes.
    Neely AN; Law EJ; Holder IA
    Infect Immun; 1986 Apr; 52(1):200-4. PubMed ID: 2420722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
    Matuschak GM; Lechner AJ
    Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immunoglobulin G and low-dose amphotericin B on Candida albicans infections in burned mice.
    Neely AN; Holder IA
    Antimicrob Agents Chemother; 1992 Mar; 36(3):643-6. PubMed ID: 1622177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinase production and pathogenicity of Candida albicans. II. Virulence for mice of C. albicans strains of different proteinase activity.
    Kondoh Y; Shimizu K; Tanaka K
    Microbiol Immunol; 1987; 31(11):1061-9. PubMed ID: 3328042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avirulence of Candida albicans FAS2 mutants in a mouse model of systemic candidiasis.
    Zhao XJ; McElhaney-Feser GE; Sheridan MJ; Broedel SE; Cihlar RL
    Infect Immun; 1997 Feb; 65(2):829-32. PubMed ID: 9009352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis.
    Jafari M; Salari S; Pakshir K; Zomorodian K
    Microb Pathog; 2017 Sep; 110():73-77. PubMed ID: 28642006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis.
    Fotedar R; Al-Hedaithy SS
    Mycoses; 2005 Jan; 48(1):62-7. PubMed ID: 15679669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Components of the increased circulating proteolytic activity in pediatric burn patients.
    Neely AN; Warden GD; Rieman M; Friedberg DL; Holder IA
    J Trauma; 1992 Dec; 33(6):807-12. PubMed ID: 1474619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant.
    Macdonald F; Odds FC
    J Gen Microbiol; 1983 Feb; 129(2):431-8. PubMed ID: 6341508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of aspartic proteases in disseminated Candida albicans infection in mice.
    Fallon K; Bausch K; Noonan J; Huguenel E; Tamburini P
    Infect Immun; 1997 Feb; 65(2):551-6. PubMed ID: 9009312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteinase activity in Candida albicans strains isolated from the oral cavity of immunocompromised patients, with oral candidiasis and in healthy subjects].
    Hernández-Solís SE; Rueda-Gordillo F; Rojas-Herrera RA
    Rev Iberoam Micol; 2014; 31(2):137-40. PubMed ID: 24071641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans proteinase as a virulence factor in the pathogenesis of Candida infections.
    Odds FC
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Dec; 260(4):539-42. PubMed ID: 3914794
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-inflammatory potential of myristic acid and palmitic acid synergism against systemic candidiasis in Danio rerio (Zebrafish).
    Prasath KG; Alexpandi R; Parasuraman R; Pavithra M; Ravi AV; Pandian SK
    Biomed Pharmacother; 2021 Jan; 133():111043. PubMed ID: 33378951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection.
    Neely AN; Hoover DL; Holder IA; Cross AS
    Burns; 1996 Nov; 22(7):524-30. PubMed ID: 8909752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a secretory proteinase of Candida parapsilosis and evidence for the absence of the enzyme during infection in vitro.
    Rüchel R; Böning B; Borg M
    Infect Immun; 1986 Aug; 53(2):411-9. PubMed ID: 3525413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.